News

Moderna Wins Narrower US Approval for New Covid Vaccine
Moderna Inc. gained US approval for a new Covid vaccine for a narrower group of people, in the latest sign that regulators ...
Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.
FDA approves Moderna’s next-generation COVID vaccine for adults 65 or older
The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.
US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older
The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...
Moderna Announces Update on Investigational Pandemic Influenza Program
H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award ...
Pfizer CEO: HHS claims of ‘concealed safety concerns’ on mRNA vaccines are ‘completely inaccurate’
Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...
Explore more
Moderna Is Imperiled by Kennedy’s Health Department. It May Run Out of Cash.
The Trump administration’s decision to yank nearly $600 million in promised bird flu vaccine funding is the latest worrying ...
Moderna suffers a $750 million loss from NIH funding cut
The amount of the funding cut is significant for a company of Moderna's size. It reported a total of $1 billion in sales for the fourth quarter of 2024, and expects 2025 revenue to be between $1.5 to ...